Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Individuals whose BMI registers at 27 or above who have weight-related health issues, such as type 2 diabetes, high blood pressure, or high cholesterol, may also be suitable candidates
Semaglutide (sold as Ozempic) was approved to treat type 2 diabetes in December 2017 and for obesity (sold as Wegovy) in June 2021
Metrics to track Beyond weight, track these metrics weekly or biweekly: Waist circumference at the navel, first thing in the morning Hip circumference at the widest point Energy level on a 1 to 10 scale Sleep quality on a 1 to 10 scale Appetite level on a 1 to 10 scale Side effects type and severity Exercise type and duration Request blood work from your provider at baseline, 12 weeks, and 24 weeks at minimum
Modifications in the regulatory climate are facilitating the introduction of new SAG products to the market, thereby enhancing consumer confidence
Compounded medication by mail
Chronic Illness/Steroids: Existing conditions or medications can inhibit bone formation
US$ 27.53
US$ 28.22
US$ 29.60
US$ 29.29
US$ 22.69
US$ 29.24
